New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
09:27 EDTLIFE, RHHBY, TMO, GELife Technologies potential buyers could have better options, says Piper Jaffray
After Life Technologies (LIFE) said it hired two investment banks to aid in its annual strategic review, Piper Jaffray said it believes a takeover or leveraged buyout is potentially in the works. Piper said it sees several potential acquirers for Life, listing Roche (RHHBY), Thermo Fisher (TMO) and General Electric (GE) as possibly making strategic sense. However, Piper says the slower growing Research Consumables business makes up 43% of Life's revenue. As such, it believes an acquirer interested in the faster growing next-gen sequencing business has better options. Piper has a Neutral rating on shares of Life Technologies.
News For LIFE;RHHBY;TMO;GE From The Last 14 Days
Check below for free stories on LIFE;RHHBY;TMO;GE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 17, 2014
06:35 EDTGEGeneral Electric reports Q1 GE Capital revenue $10.52B
Subscribe for More Information
06:32 EDTGEGeneral Electric reports Q1 adjusted EPS 33c, consensus 32c
Reports Q1 revenue $34.18B, consensus $34.36B
06:18 EDTRHHBYEMA warns that stolen Roche drug found on market
The European Medicines Agency has been informed that vials of the cancer medicine Herceptin, thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries. This is currently being investigated by Member State authorities and updates will be provided as more information becomes available. Italian law enforcement authorities are currently investigating the theft and are looking at whether other medicines may also be affected. No affected product has so far been identified at hospital level and there are no reports that any harm has come to patients in relation to the falsified medicine and authorities are working to avoid this. The marketing authorisation holder for Herceptin is Roche.
April 16, 2014
15:17 EDTGENotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include General Electric (GE), consensus 32c; Philip Morris (PM), consensus $1.16; Schlumberger (SLB), consensus $1.20; PepsiCo (PEP), consensus 75c; Union Pacific (UNP), consensus $2.37; UnitedHealth (UNH), consensus $1.09; Honeywell (HON), consensus $1.26; Goldman Sachs (GS), consensus $3.44; du Pont (DD), consensus $1.59; Morgan Stanley (MS), consensus 60c; Danaher (DHR), consensus 80c; BlackRock (BLK), consensus $4.14; Blackstone (BX), consensus 55c; Chipotle Mexican Grill (CMG), consensus $2.86; Mattel (MAT), consensus 9c; Snap-on (SNA), consensus $1.54; AutoNation (AN), consensus 74c.
14:13 EDTGEGeneral Electric April 26 straddle priced for 2.5% move into Q1
12:22 EDTGEEarnings Preview: Analyst sentiment mixed ahead of GE's Q1 report
Subscribe for More Information
09:03 EDTGEGE Digital Energy providing series compensation capabilities for Scottish Power
Subscribe for More Information
07:32 EDTRHHBYRegeneron may be taking market share from Roche, says Brean Capital
Subscribe for More Information
07:13 EDTGEGeneral Electric April volatility elevated into Q1 and revenue outlook
Subscribe for More Information
April 15, 2014
10:18 EDTGEGE Healthcare completes acquisition of CHCA Computer Systems
Subscribe for More Information
10:01 EDTGEGeneral Electric says Dan Janki to lead GE's Treasury operations
GE Chairman and CEO Jeff Immelt announced the appointment of Dan Janki to lead GEís Treasury operations, succeeding Kathy Cassidy, who is retiring later this year after 35 years of service to GE. Mark Begor, who currently leads GE Capitalís Real Estate business, will succeed Janki as president & CEO of GE Energy Management. Alec Burger, currently the North America leader for GE Capital Real Estate, will succeed Mark Begor as president & CEO of GE Capital Real Estate. The CEO appointments are effective immediately and the formal Treasury transition will be effective by the end of April.
09:02 EDTRHHBYRoche confirms FY outlook for low-to mid-single digit growth in sales
Subscribe for More Information
09:01 EDTRHHBYRoche reports Q1 sales CHF11.496B vs. CHF11.589B a year ago
Roche reported Q1 group sales rose 5% at constant exchange rates and fell 1% in Swiss francs compared to the prior year. Pharma sales were up 4%, with continued growth of Avastin, MabThera/Rituxan, Actemra/RoActemra and Herceptin compensating for expected decline in Xeloda sales, while Diagnostics division sales were up 7%. Roche CEO Severin Schwan said: ďBoth the Pharma and Diagnostics Divisions posted solid growth in the first quarter. I am particularly pleased with the strong uptake of our recently launched medicines Perjeta and Kadcyla for HER2-positive breast cancer."
08:23 EDTRHHBYLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:19 EDTRHHBYLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
06:32 EDTRHHBYPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
06:04 EDTGEGE CEO may give up leadership earlier than 20-year tenure, WSJ says
Subscribe for More Information
April 14, 2014
11:54 EDTGEGE reports Omnyx gets FDA clearance for digital manual read of HER2 slides
Subscribe for More Information
April 10, 2014
11:42 EDTRHHBYReport claims Tamiflu, Relenza do little to prevent the spread of flu
Subscribe for More Information
09:03 EDTGEGE to provide grid modernization solutions to Furnas
GEís Digital Energy business is providing Furnas and Triangulo Mineiro Transmissora/Geoenergia with the latest in protection and control equipment to ensure performance and quality for each of the utilityís grid modernization projects. Furnas is one of the biggest utilities in Latin America and is responsible for power transmission in south, southeast and mid west Brazil. These projects, which support the modernization of Brazilís grid, mark GEís entry into Brazilís ANEEL transmission auctions. The auctions were won in December 2013 by TMT, a collaborative utility composed of Furnas and FIP Milao, with Furnas being the largest participant at 49%.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use